Doctiplus - We are allways here!
Heart Disease & Cardiovascular
Weekly Report
- 109 new clinical trials registered across 10 countries.
- 8,744 trials actively recruiting patients worldwide.
- Notable trial: Pulmonary Embolism Registry From Emergency to Long-Term Follow-Up and Surveillance (5000 patients).
- 3,994 new research papers published.
- Drug safety: Most reported effect across tracked medications (atorvastatin, lisinopril, metoprolol, amlodipine, warfarin) was Fatigue.
- No active drug recalls for tracked medications this week.
The week in numbers
Trials by country
Trials by phase
New clinical trials registered this week for Heart Disease & Cardiovascular. Each trial links to its full record on ClinicalTrials.gov where you can find eligibility criteria, locations, and contact information.
This week's new registrations
109 trials registered for Heart Disease & Cardiovascular. Each links to its full record on ClinicalTrials.gov.
| # | Trial ↓ | Phase ↕ | Status ↕ | Enrollment ↕ | Country ↕ |
|---|---|---|---|---|---|
| 01 | Combined Acupuncture-Based Therapy for Rehabilitation After Ischemic Stroke Heart Disease & Cardiovascular · National Hospital of Acupuncture, Vietnam (NCT07846488) | Other | Not Yet Recruiting | 440 | Vietnam |
| 02 | Uric Acid to Albumin Ratio for Predicting Contrast Associated Acute Kidney Injury After Cardiac and Non Cardiac Procedures Heart Disease & Cardiovascular · Assiut University (NCT07855653) | Other | Not Yet Recruiting | 100 | N/A |
| 03 | Comparison of Thrombin Generation, Platelet Activation and Aggregation Profiles in Patients With Sickle Cell Disease Depending on Their SS or SC Genotype (DrepAgreg) Heart Disease & Cardiovascular · Centre Hospitalier Universitaire de la Guadeloupe (NCT07852442) | Other | Not Yet Recruiting | 60 | France |
| 04 | Corticosteroid for Diabetic Macular Edema (DME) Study Heart Disease & Cardiovascular · Vanderbilt University Medical Center (NCT07843849) | Phase 4 | Recruiting | 20 | United States |
| 05 | a Prospective, Multicenter, Randomized Controlled Trial, With a Non-randomized Sentinel Cohort, Evaluating the Efficacy of Bioxheal, a Single-layer Placental-derived Biologic in Nonhealing Diabetic Foot Ulcers Heart Disease & Cardiovascular · Applied Biologics, LLC (NCT07852338) | Phase 3 | Recruiting | 253 | United States |
| 06 | Deep Brain Stimulation + Therapy for Stroke Heart Disease & Cardiovascular · Pirondini, Elvira, PhD (NCT07849114) | Other | Not Yet Recruiting | 15 | United States |
| 07 | Can Exercise Electrocardiography Discriminate Hypertensive Heart Disease From Obstructive Coronary Artery Disease? A Multimodality Imaging Study Heart Disease & Cardiovascular · University of Pisa (NCT07847463) | Other | Recruiting | 30 | Italy |
| 08 | ENDOBARIHEART STUDY Heart Disease & Cardiovascular · Maria Cecilia Hospital (NCT07847307) | Other | Not Yet Recruiting | 50 | Italy |
| 09 | Music Intervention to Reduce Anxiety and Prevent Delirium in Older Adults Undergoing Cardiac Surgery Heart Disease & Cardiovascular · KU Leuven (NCT07851194) | Other | Not Yet Recruiting | 256 | Belgium |
| 10 | Right Heart and Lung Blood Flow During Exercise (RIGHT-NET 2.0) Heart Disease & Cardiovascular · IRCCS SYNLAB SDN (NCT07851610) | Other | Not Yet Recruiting | 2,000 | N/A |
| 11 | Clinical Predictors and Therapeutic Gaps in CKM Syndrome Among Adults With Type 2 Diabetes Heart Disease & Cardiovascular · Assiut University (NCT07854990) | Other | Not Yet Recruiting | 231 | Egypt |
| 12 | Pulmonary Embolism Registry From Emergency to Long-Term Follow-Up and Surveillance Heart Disease & Cardiovascular · Azienda Ospedaliero-Universitaria Careggi (NCT07855679) | Other | Recruiting | 5,000 | Italy |
| 13 | Exercise Phenotyping Prior to Chemotherapy in Newly Diagnosed Multiple Myeloma (MM-Exercise) Heart Disease & Cardiovascular · Technical University of Munich (NCT07851493) | Other | Recruiting | 80 | Germany |
| 14 | Glial Fibrillary Acidic Protein Testing and Handheld Near Infrared Spectroscopy Technology CEREBO in India. Heart Disease & Cardiovascular · Christian Medical College and Hospital, Ludhiana, India (NCT07844109) | Other | Not Yet Recruiting | 232 | India |
| 15 | Walnuts for Cardiorenal Protection in Adults With Chronic Kidney Disease Heart Disease & Cardiovascular · Institut Investigacio Sanitaria Pere Virgili (NCT07851454) | Other | Recruiting | 150 | Spain |
| 16 | Educational Intervention for Self-Care in Patients With Coronary Heart Disease and Type 2 Diabetes Heart Disease & Cardiovascular · Suleyman Demirel University (NCT07852715) | Other | Completed | 70 | Turkey (Türkiye) |
| 17 | Invasive Versus Non-Invasive Intracranial Pressure-Guided Management in Neurosurgical Patients Heart Disease & Cardiovascular · Kathmandu Medical College and Teaching Hospital (NCT07853963) | Other | Completed | 40 | Nepal |
| 18 | ABVN Phase 2 - EDS Wearable Device Heart Disease & Cardiovascular · Indiana University (NCT07856459) | Other | Completed | 58 | United States |
| 19 | Aficamten and Patient-Reported Outcomes in Real-World nHCM Heart Disease & Cardiovascular · Second Affiliated Hospital, Zhejiang University, School of Medicine (NCT07846176) | Other | Not Yet Recruiting | 100 | N/A |
| 20 | Laser Hemorrhoidoplasty Versus Open Hemorrhoidectomy for Postoperative Pain Heart Disease & Cardiovascular · Allied Hospital Faisalabad (NCT07846904) | Other | Not Yet Recruiting | 68 | N/A |
| 21 | Walk Together Efficacy Trial Heart Disease & Cardiovascular · University of Texas Southwestern Medical Center (NCT07849920) | Other | Not Yet Recruiting | 400 | United States |
| 22 | Ice Packing Versus Warm Sitz Baths After Hemorrhoidectomy Heart Disease & Cardiovascular · Memorial Atasehir Hospital (NCT07843563) | Other | Completed | 89 | Turkey (Türkiye) |
| 23 | Pivotal Trial for an Automated AI-based System for Detection of Diabetic Retinopathy Heart Disease & Cardiovascular · Digital Diagnostics, Inc. (NCT07844317) | Other | Recruiting | 800 | United States |
| 24 | Early Postoperative Triple Targeted Therapy in Patients With CHD-PAH in the "Grey Zone" Heart Disease & Cardiovascular · China National Center for Cardiovascular Diseases (NCT07844213) | Other | Completed | 30 | China |
| 25 | Patient Selection and Long-Term Outcomes of Pace & Ablate Strategy in Atrial Fibrillation Heart Disease & Cardiovascular · Insel Gruppe AG, University Hospital Bern (NCT07852221) | Other | Recruiting | 2,600 | Poland |
| 26 | Monitoring Blood Pressure at Home and Pharmacy Telehealth Among People Living With HIV Heart Disease & Cardiovascular · University of Alabama at Birmingham (NCT07849595) | Other | Not Yet Recruiting | 572 | N/A |
| 27 | PCSK9 Inhibitors in Hyperlipidemia and Atherosclerosis Heart Disease & Cardiovascular · Fundación Santa Fe de Bogota (NCT07856264) | Other | Not Yet Recruiting | 100 | N/A |
| 28 | NAION in Non-Diabetic Obese Patients Using GLP-1 Receptor Agonists: A Real-World Study Heart Disease & Cardiovascular · Istanbul Saglik Bilimleri University (NCT07846956) | Other | Not Yet Recruiting | 28 | Turkey (Türkiye) |
| 29 | Effect of Two Weeks of Low-Dose Apixaban on Platelet Reactivity in Patients With Stable Coronary Artery Disease on Dual Antiplatelet Therapy (Aspirin and Clopidogrel) Heart Disease & Cardiovascular · The University of The West Indies (NCT07853612) | Phase 4 | Active Not Recruiting | 16 | Trinidad and Tobago |
| 30 | Biomarkers as Prognostic Factors of Silent, Cerebral Infarctions in Patients Undergoing High-thromboembolic-risk Transcatheter Interventions Heart Disease & Cardiovascular · Aristotle University Of Thessaloniki (NCT07844850) | Other | Recruiting | 100 | Greece |
| 31 | Edoxaban Versus Apixaban in Cancer-Associated Venous Thromboembolism Heart Disease & Cardiovascular · Samsung Medical Center (NCT07852637) | Phase 4 | Not Yet Recruiting | 2,300 | South Korea |
| 32 | Molecular Autopsy in Young Individuals With Sudden Cardiac Death Heart Disease & Cardiovascular · University of Sao Paulo (NCT07849738) | Other | Recruiting | 200 | Brazil |
| 33 | Intranasal Dexmedetomidine and Perioperative Myocardial Injury in Patients Having Percutaneous Coronary Interventions Heart Disease & Cardiovascular · Second Affiliated Hospital, Zhejiang University, School of Medicine (NCT07847580) | Other | Not Yet Recruiting | 2,500 | China |
| 34 | Brave Heart Intervention and Mental Health Outcomes Among Young People in Sierra Leone Heart Disease & Cardiovascular · Slum and Rural Health Initiative (NCT07853092) | Other | Completed | 2,244 | Sierra Leone |
| 35 | Sacubitril/Valsartan Versus Valsartan Alone on Left Atrial Volume Index in Hypertensive Patients Heart Disease & Cardiovascular · University of Health Sciences Lahore (NCT07853625) | Other | Not Yet Recruiting | 102 | N/A |
| 36 | OPTIMized Diagnosis and Treatment System Based on AI and Multimodal Imaging Fusion for PCI (OPTIMAI-PCI) Heart Disease & Cardiovascular · Zhejiang Hospital (NCT07855614) | Other | Not Yet Recruiting | 554 | China |
| 37 | Direct Electrical Stimulation of Central Autonomic Network for Blood Pressure Control: a Mechanism Study Heart Disease & Cardiovascular · Xuanwu Hospital, Beijing (NCT07844239) | Other | Not Yet Recruiting | 20 | N/A |
| 38 | The Effect of Telerehabilitation Exercises in Children With Congenital Heart Disease Heart Disease & Cardiovascular · Izmir Democracy University (NCT07854171) | Other | Not Yet Recruiting | 32 | Turkey (Türkiye) |
| 39 | Aspirin 50mg vs 100mg Combined With P2Y12 Inhibitor After PCI Heart Disease & Cardiovascular · Jilin University (NCT07846462) | Other | Recruiting | 2,640 | China |
| 40 | The Effect of Virtual Reality Headsets on Pain, Anxiety, Patient Satisfaction, and Physiological Parameters in Patients Undergoing Open-Heart Surgery Heart Disease & Cardiovascular · Dokuz Eylul University (NCT07843511) | Other | Not Yet Recruiting | 44 | Turkey (Türkiye) |
| 41 | Nurse-Led Self-Management and Breathing Intervention in Type 2 Diabetes Heart Disease & Cardiovascular · Aziza Ibrahim Mohamed (NCT07847177) | Other | Completed | 80 | Egypt |
| 42 | Withdrawal of Heart Failure Treatment Patients With Non-ischemic Cardiomyopathy Who Have Been Super-responders to Cardiac Resynchronization Therapy. Heart Disease & Cardiovascular · Institut d'Investigació Biomèdica de Bellvitge (NCT07851779) | Phase 4 | Recruiting | 64 | Spain |
| 43 | [11C]PS13 PET Imaging of Neuroinflammation in Heart Failure With Reduced Ejection Fraction Heart Disease & Cardiovascular · Stony Brook University (NCT07856043) | Phase 1 | Not Yet Recruiting | 18 | United States |
| 44 | The CANadian EXAcerbation of COPD Trial Heart Disease & Cardiovascular · McGill University Health Centre/Research Institute of the McGill University Health Centre (NCT07850648) | Other | Not Yet Recruiting | 125 | Canada |
| 45 | wCAR-Austria: A Women-Specific Score to Assess Cardiovascular Risk in Women Aged 40 to 65 Heart Disease & Cardiovascular · Women's Heart Austria (NCT07849127) | Other | Not Yet Recruiting | 800 | Austria |
| 46 | Minicrush Versus Culotte Stenting in Complex Coronary Bifurcation Lesions:The Multicenter T-REX II Registry Heart Disease & Cardiovascular · San Luigi Gonzaga Hospital (NCT07849335) | Other | Enrolling By Invitation | 500 | Italy |
| 47 | Neuromuscular Electrical Stimulation in Peripheral Arterial Disease Heart Disease & Cardiovascular · Halic University (NCT07851766) | Other | Completed | 48 | Turkey (Türkiye) |
| 48 | Two-Week Stair-Climbing Exercise Snacks and Metabolic Health in Adults With Overweight or Obesity: A Pilot Study Heart Disease & Cardiovascular · St. Louis University (NCT07849439) | Other | Recruiting | 12 | United States |
| 49 | Acute Effects of Physiotherapy Interventions on Biceps Brachii Muscle Tissue Perfusion After Stroke Heart Disease & Cardiovascular · Izmir Bakircay University (NCT07853859) | Other | Completed | 26 | Turkey (Türkiye) |
| 50 | COOLing of the Ischemic PENumbra in Patients With Acute Ischemic Stroke. Heart Disease & Cardiovascular · Christian Medical College and Hospital, Ludhiana, India (NCT07844096) | Other | Not Yet Recruiting | 55 | India |
Adverse event reports
Adverse drug event reports compiled from the FDA's FAERS database for medications commonly prescribed for Heart Disease & Cardiovascular. These reports reflect what patients and healthcare providers have reported — they do not confirm a drug caused the effect.
Reports by drug
| Drug | Top effect | Count |
|---|---|---|
| atorvastatin | Fatigue | 1,084 |
| lisinopril | Fatigue | 1,493 |
| metoprolol | Fatigue | 1,783 |
| amlodipine | Fatigue | 2,134 |
| warfarin | Off Label Use | 239 |
Recalls & safety notices
FDA drug recall notices for medications related to Heart Disease & Cardiovascular. If your medication is listed, contact your pharmacist or visit fda.gov/safety/recalls for guidance. No recall listed does not guarantee safety — always consult your healthcare provider.
No active drug recalls for tracked medications this period.
Published research
Recently published peer-reviewed studies related to Heart Disease & Cardiovascular, sourced from PubMed and Semantic Scholar. Click any title to read the full paper, or expand the abstract for a quick summary.
| # | Study | Journal | Date | Source |
|---|---|---|---|---|
| 01 |
Readiness for Hospital Discharge and Quality of Life Among Patients Undergoing Surgery for Type A Aortic Dissection: A Prospective Observational Cohort Study.
View abstractAIMS: To examine the level and associated factors of readiness for hospital discharge among patients undergoing surgery for type A aortic dissection, and its correlations with quality of life at 30 and 90 days post-discharge. DESIGN: A prospective observational cohort study with a cross-sectional baseline assessment and longitudinal follow-up at 30 and 90 days post-discharge. METHODS: This study employed a convenience sampling method to recruit 186 patients who underwent surgery for type A aortic dissection at the Department of Cardiovascular Surgery of a tertiary hospital in northern China between January 2024 and June 2025. Baseline data were collected within 24 h before discharge using the Readiness for Hospital Discharge Scale, the All Aspects of Health Literacy Scale, the Perceived Social Support Scale, and the Quality of Discharge Teaching Scale. Quality of life was assessed 30 and 90 days after discharge using the 8-item Short Form Health Survey. Descriptive statistics, correlation analysis, and multiple linear regression analysis (enter method) were used to analyse the data. RESULTS: A total of 186 patients completed baseline assessment (184 at 30 days; 180 at 90 days). The mean readiness for hospital discharge score was 153.74 ± 31.85, with a mean item score of 6.99 ± 1.45, indicating low readiness. Multiple linear regression analysis revealed that quality of discharge teaching, social support, health literacy, and having a college degree or above were the main associated factors of readiness for hospital discharge. Together, these associated factors accounted for 30.0% of the total variance. Spearman's correlation analysis revealed positive correlations between readiness for hospital discharge and quality of life at 30 and 90 days. CONCLUSION: Patients undergoing surgery for type A aortic dissection have low readiness for hospital discharge, which is associated with quality of discharge teaching, social support, health literacy, and educational level. Greater readiness was associated with better quality of life at 30 and 90 days post-discharge. IMPLICATION FOR PRACTICE: Nurses should assess discharge readiness and provide targeted transitional care, particularly for patients with lower education, limited health literacy, or insufficient social support. Future intervention studies are needed to test whether enhancing readiness improves outcomes. REPORTING METHOD: This study adhered to the STROBE reporting guidelines. PATIENT OR PUBLIC CONTRIBUTION: No patient or public contribution. |
Nursing open | 2026 Oct | PubMed |
| 02 |
Health Economic & Implementation Determinants of Prehospital Stroke Triage Tools: A Systematic Review.
View abstractRATIONALE: Effective prehospital stroke triage enables faster treatment and better patient outcomes. Although prehospital triage innovations are rapidly emerging, evidence regarding the balance between costs and benefits as well as implementation issues remains limited. AIMS AND OBJECTIVES: This review aims to synthesise published evidence on health economics and implementation determinants of prehospital triage tools for acute suspected ischaemic stroke patients. METHOD: A systematic search was conducted across five databases (CINAHL, Cochrane, EMBASE, PubMed, and Web of Science) between 1995 and 2025. Results were reported narratively, and reporting quality was assessed using CHEERS, STROBE-simulation, COREQ, CONSORT, SQUIRE, and GRAMMS. Included were empirical studies of EMS-operated prehospital triage innovations for acute suspected stroke patients. The main outcome measures were health economic outcomes (e.g., ICER) and system-level implementation determinants (CFIR constructs). RESULTS: From 6491 screened studies, thirty-one were included: thirteen studies included health economic outcomes and eighteen reported implementation determinants. Prehospital triage tools assessed were: MSU (n = 14), telemedicine (n = 13), clinimetrics (n = 1), prehospital MRI (n = 1), biomarkers (n = 1), and an AI-based microwave tool (n = 1). Most studies (68%) were of high reporting quality. Positive results regarding cost-effectiveness were reported (n = 11), including cost-savings (n = 1), as well as implementation determinants (n = 11). However, evidence on sustained implementation was limited. Barriers included innovation design, complexity, workflow compatibility, work and IT infrastructure, and costs. CONCLUSION: Included studies suggest most prehospital stroke triage tools are cost-effective, but implementation remains largely context-dependent. Barriers, including innovation complexity, role delineation, workflow fit, design, and costs, highlight the need for future studies to integrate health economics into an implementation science framework alongside clinical outcomes. |
Journal of evaluation in clinical practice | 2026 Oct | PubMed |
| 03 |
Advances in left bundle branch area pacing: current evidence, clinical applications, and future perspectives.
View abstractINTRODUCTION: Left bundle branch area pacing (LBBAP) resynchronizes the left ventricle through the conduction system rather than through a coronary sinus lead, and is increasingly used as an alternative to biventricular pacing (BVP) for cardiac resynchronization therapy (CRT) in heart failure with reduced ejection fraction. AREAS COVERED: Drawing on a search of PubMed, Embase, the Cochrane Library and ClinicalTrials.gov from January 2015 through September 2026, this review covers the anatomical basis of LBBAP, implantation and confirmation of capture, complications, observational and randomized comparisons with BVP, guideline and consensus positions, and emerging technologies from ultra-high-frequency electrocardiography to leadless pacing. EXPERT OPINION: Registries and meta-analyses favor LBBAP, but six randomized trials point in different directions, from inferiority to a large reduction in death or heart failure hospitalization over three years. Where capture type was reported, outcome followed confirmed conduction system capture more closely than randomized allocation, a pattern that is consistent but unproven. Until trials with hard endpoints report capture type, we would place LBBAP first in centers able to document conduction system capture in most of their patients, and keep BVP as the default elsewhere. |
Expert review of cardiovascular therapy | 2026 Oct 4 | PubMed |
| 04 |
Development and Validation of a Predictive Model for Subclinical Myocardial Dysfunction in Breast Cancer Patients Receiving Doxorubicin-Based Chemotherapy: Integrating 2D Speckle Tracking Echocardiography and Conventional Echocardiographic Parameters.
View abstractBACKGROUND: Anthracycline cardiotoxicity is often silent at the subclinical stage. Left ventricular ejection fraction (LVEF) detects injury late, and global longitudinal strain (GLS) is sensitive but usually used alone. This study aimed to develop and internally validate a baseline model combining speckle-tracking GLS, conventional echocardiography, and clinical factors to identify women at high risk of subclinical myocardial dysfunction before doxorubicin (DOX) chemotherapy. METHODS: In a single-center prospective study, 200 breast cancer patients scheduled for DOX-based chemotherapy underwent baseline and 1-month assessment. The primary outcome was subclinical myocardial dysfunction, defined as > 15% relative GLS reduction with preserved LVEF. P < 0.10 variables in univariable analysis entered multivariable logistic regression for nomogram construction. Discrimination, calibration, and decision curve analysis used 1000-bootstrap validation. RESULTS: Subclinical myocardial dysfunction occurred in 60 of 200 patients (30.0%). Independent predictors were baseline GLS, LDL-C, trastuzumab use, planned cumulative dose, LAVI, and hypertension. The model reached an AUC of 0.803, higher than baseline GLS, a clinical-only model, and baseline LVEF. The bootstrap-corrected C-index was 0.777. CONCLUSION: A baseline nomogram combining GLS, conventional echocardiography, and clinical factors may help identify patients at high risk of early subclinical myocardial dysfunction before chemotherapy, outperforming single parameters and supporting risk-stratified monitoring. |
Echocardiography (Mount Kisco, N.Y.) | 2026 Oct | PubMed |
| 05 |
Variants in CEP135 Cause Congenital Microcephaly and Primary Ciliary Dyskinesia.
View abstractINTRODUCTION: Primary ciliary dyskinesia (PCD), a disorder of motile ciliary dysfunction causing chronic respiratory infections, may also rarely present with aspects of non-motile ciliary dysfunction, including retinitis, central nervous system malformations, skeletal dysplasia, and sensorineural hearing loss. However, congenital microcephaly has not been previously associated with PCD. METHODS: We identified three children with congenital microcephaly and chronic respiratory disease consistent with PCD. Comprehensive PCD diagnostic testing and whole exome sequencing were performed. Characterization of nasal epithelial cells after expansion and regrowth included reverse transcription polymerase chain reaction, high speed videomicroscopy, and transcript analysis of novel genetic variants. RESULTS: Three pediatric cases from two families had primary microcephaly from autosomal recessive variants in CEP135. All cases displayed chronic suppurative respiratory symptoms, recurrent otitis media, and bronchiectasis with low nasal nitric oxide. One case had pathogenic, compound heterozygous, loss of function variants, while the other two cases had homozygous variants of uncertain significance. Transcript analyses of CEP135 variants of uncertain significance supported a splicing defect as disease-causing. Regrown nasal epithelial cells demonstrated overall normal ciliary ultrastructure with decreased numbers of full-length axonemes. Ciliary beat pattern was grossly abnormal, and distal axoneme swelling with bulbous-tip structures were identified pre- and post-cellular regrowth. CONCLUSION: These cases establish variants in CEP135 as a novel cause of PCD with microcephaly. The TEM findings of bulbous ciliary tips may be a reliable marker of overlapping ciliopathies in patients with aspects of motile and non-motile ciliary dysfunction. |
Pediatric pulmonology | 2026 Oct | PubMed |
| 06 |
Longitudinal Impact of Pseudomonas aeruginosa Versus Haemophilus influenzae Colonization on Lung Function Decline in Children With Primary Ciliary Dyskinesia.
View abstractBACKGROUND: The association of Pseudomonas aeruginosa (PsA) and Haemophilus influenzae (HI) colonization with lung function in children with primary ciliary dyskinesia (PCD) remains insufficiently defined. We aimed to compare spirometric parameters between PsA- and HI-colonized children and evaluate longitudinal changes before, at, and after chronic colonization. METHODS: This retrospective cohort included patients aged ≥ 5 years with definite or highly probable PCD and chronic PsA or HI colonization. Chronic colonization was defined using repeated sputum cultures over 12 months. Pulmonary function tests were analyzed 1 year before colonization, at colonization, and 1 year after colonization. FEV1, FVC, and FEF25-75 were reported as percent-predicted values and GLI 2012 z-scores. Individual pre-to-after-colonization change scores and bronchiectasis subgroup analyses were performed. RESULTS: Among 290 patients with PCD, 40 met inclusion criteria: 10 with PsA and 30 with HI colonization. PsA-colonized patients were older at colonization than HI-colonized patients (17 [12-23] vs. 11 [9-15] years, p = 0.011), and bronchiectasis was more frequent in the PsA group (100% vs. 60%, p = 0.019). PsA colonization was associated with lower lung function across several spirometric measures. Both groups showed significant within-group declines in FEV1 and FEF25-75 over time. However, individual pre-to-after-colonization changes in FEV1 and FEF25-75 z-scores did not differ significantly between groups, including in the bronchiectasis subgroup analysis. CONCLUSIONS: PsA colonization was associated with lower lung function than HI colonization, but not with significantly greater longitudinal decline. These findings suggest that PsA may mark more advanced disease rather than independently accelerating functional loss. Larger prospective studies with non-colonized comparators are needed. |
Pediatric pulmonology | 2026 Oct | PubMed |
| 07 |
Cardiomyocyte Membrane-Camouflaged Spinach Nano-Thylakoids Enhance Myocardial Energy Metabolism and Ameliorate Heart Failure.
View abstractBACKGROUND: Energy deficiency and mitochondrial dysfunction are key features of heart failure (HF), while current therapies only indirectly improve cardiac metabolism. We developed a biomimetic photoactivatable nanoplatform, cardiomyocyte membrane-camouflaged photosynthetic nano-thylakoids (MM-NTU), to enhance myocardial bioenergetics. METHODS AND RESULTS: Nano-thylakoids were isolated from spinach chloroplasts, downsized, and coated with cardiomyocyte membranes to improve cardiac association and retention. In transverse aortic constriction (TAC) rats, intramyocardial MM-NTU administration combined with red-light activation improved systolic function, reduced fibrosis, and attenuated ventricular remodeling. In angiotensin II-injured cardiomyocytes, MM-NTU stabilized mitochondrial membrane potential, increased ATP production, and suppressed hypertrophic and profibrotic markers. Multi-omics analyses revealed restoration of glucose-related metabolites and mitochondrial energy intermediates, reduced oxidative stress, and improved bioenergetic efficiency. MM-NTU also modulated AMPK-related signaling and altered Pck1 and Adipoq expression, consistent with enhanced glucose utilization. Biodistribution and histological analyses showed favorable biocompatibility without evident major-organ toxicity. CONCLUSIONS: MM-NTU enhances ATP generation, glucose utilization, and mitochondrial energy metabolism, thereby improving myocardial bioenergetics and cardiac function under pressure overload. |
Small (Weinheim an der Bergstrasse, Germany) | 2026 Oct 4 | PubMed |
| 08 |
Loss of function variants in ADAMTS6: a new connective tissue disorder with heart defect, aortic aneurysm and neurodevelopmental features.
View abstractPURPOSE: Marfan syndrome, Loeys-Dietz syndrome, and heritable thoracic aortic aneurysms and dissections (hTAAD) are autosomal dominant connective-tissue disorders with overlapping features and considerable genetic variability. Many cases arise from pathogenic variants affecting extracellular matrix (ECM) components or TGFβ signaling, yet a substantial proportion of hTAAD cases remain genetically unexplained. This study aimed to identify new genetic contributors to aortic disease and to clarify their molecular and clinical impact. METHODS: Exome and genome sequencing of a French cohort with syndromic or isolated hTAAD revealed rare damaging variants in ADAMTS6 in four unrelated individuals. RESULTS: Functional analyses showed that these variants impaired ADAMTS6 secretion and catalytic activity, disrupting the processing of fibrillin-1 and fibrillin-2, leading to abnormal ECM accumulation and disorganized microfibrils. The recurrent p.(Leu814Arg) variant additionally altered Hippo and TGFβ signaling and affected cell adhesion. Patient-derived fibroblasts and Adamts6-deficient mice exhibited parallel pathological defects, supporting ADAMTS6 loss-of-function as disease-causing Clinically, presentations ranged from early-onset multisystem disease with cardiovascular, skeletal, craniofacial, and neurodevelopmental abnormalities to isolated adult-onset aortic aneurysm. CONCLUSION: these findings establish ADAMTS6 deficiency as a newly recognized connective-tissue disorder with heart defects, aortic aneurysm, and neurodevelopmental features, highlighting ADAMTS6's key role in ECM integrity. |
Genetics in medicine : official journal of the American College of Medical Genetics | 2026 Oct 3 | PubMed |
| 09 |
Identification of Risk Factors and Prediction Models for Acute Kidney Injury in Hospitalized Elderly Patients with Heart Failure.
View abstractBACKGROUND: Elderly heart failure (HF) patients have an increased risk of acute kidney injury (AKI) during hospitalization. Identifying risk factors and developing a prediction model are clinically important. STUDY METHOD: We retrospectively enrolled 7076 elderly HF patients hospitalized from January 2019 to December 2023. All predictors were restricted to data available within 24 hours of admission and prior to AKI occurrence. Candidate predictors were first screened by univariate analysis (P<0.05) and then further refined by LASSO regression, and the selected variables were ultimately entered into multivariable logistic regression. Thirteen machine learning models were constructed and compared to identify the optimal model. Model performance was evaluated using the area under the ROC curve, calibration curves, and decision curve analysis. RESULTS: AKI occurred in 796 patients (11.2%). The final model included diuretic use, hypertension, diabetes, valvular heart disease, COPD, CKD, admission cystatin C, and LVEF. Among the 13 machine learning models, logistic regression performed best in the validation set (AUC = 0.804, 95% CI: 0.777-0.830). Calibration was acceptable in both the training and validation sets, with Hosmer-Lemeshow P values of 0.561 and 0.605, calibration slopes of 0.896 and 0.835, and Brier scores of 0.078 and 0.082, respectively. Decision curve analysis confirmed its clinical utility. A nomogram was constructed for model visualization. CONCLUSION: In this single-center study with internal validation only, the prediction model demonstrated favorable performance for in-hospital AKI in elderly HF patients and may serve as a candidate tool for early risk stratification. External validation in independent cohorts is required before routine clinical implementation. |
Clinical interventions in aging | 2026 | PubMed |
| 10 |
Cardiac Resynchronization as an Enabler of ARNI Efficacy: Insights From a Real-World Cohort.
View abstractBACKGROUND: Sacubitril/valsartan (ARNI) improves outcomes in heart failure with reduced ejection fraction (HFrEF). In patients undergoing cardiac resynchronization therapy (CRT), the potential synergy between device-based and pharmacological strategies remains underexplored. METHODS: The aim of this study was to assess the effect of ARNI therapy on reverse remodeling, clinical response, and cardiovascular events at 1 year in CRT recipients, in order to clarify the potential synergistic role of pharmacological and device-based strategies. A retrospective cohort of 194 consecutive CRT patients was analyzed, of whom 65 (33.5%) received ARNI. Echocardiographic response was defined as an increase in LVEF > 5% or ≥ 15% reduction in LV end-systolic volume at 12 months; clinical response as an improvement of at least one NYHA class. The primary endpoint was echocardiographic response. Device-detected remote monitoring heart failure (RM-HF) events were pre-specified as the key time-to-event endpoint, while mortality and HF hospitalization were exploratory. RESULTS: Baseline characteristics were comparable, although systolic blood pressure was higher in ARNI recipients. At 12 months, ARNI therapy was associated with greater reverse remodeling (ΔLVEF 14.4% ± 10.2% vs. 10.8% ± 11.0%, = 0.04). Rates of echocardiographic (68% vs. 67%) and clinical response (68% vs. 74%) were similar. Mortality and HF hospitalization did not differ significantly. In contrast, ARNI recipients showed fewer RM-HF events, with higher event-free survival among echocardiographic responders (95.7% vs. 82.6%; log-rank = 0.021, = 0.042) and clinical responders (93.4% vs. 85.3%; = 0.040, = 0.040). CONCLUSIONS: In this real-world CRT cohort, ARNI therapy enhanced reverse remodeling and reduced subclinical congestion events detected by remote monitoring. These findings support a synergistic interaction between CRT and ARNI, where resynchronization provides the substrate for pharmacological efficacy. |
Journal of arrhythmia | 2026 Oct | PubMed |
| 11 | Unexplained Acute Life-Threatening Right Heart Failure During Hip Surgery. | Acute medicine & surgery | 2026 Jan-Dec | PubMed |
| 12 |
Optimization of the Sequence of Computed Tomography Angiography and Perfusion in One-Stop-Shop CT Imaging for Acute Ischemic Stroke.
View abstractBACKGROUND In the "one-stop-shop" stroke computed tomography (CT) scanning protocol, CT perfusion (CTP) can be performed either before or after CT angiography (CTA). This study analyzed the effect of different scanning strategies in one-stop-shop stroke CT on CTA image quality and perfusion parameters, aiming to optimize the scanning sequence of CTP and CTA in the one-stop-shop stroke CT protocol. MATERIAL AND METHODS We retrospectively analyzed 115 patients with suspected acute ischemic stroke admitted to our hospital between March and June 2024 and implemented 2 scanning strategies: CTP before CTA (group A, n=51) and CTA before CTP (group B, n=64) using 64-row CT equipment. The differences in CT values of the basilar artery, middle cerebral artery, superior sagittal sinus, and straight sinus, as well as craniocerebral perfusion parameter values and subjective scores of the CTA image quality, were compared between the 2 groups. The difference between venous CT values and the expert consensus-recommended intracranial venous CT value of 150 Hounsfield units (HU) was also compared. RESULTS There were no significant differences in arterial CT values or perfusion parameter values between groups A and B (P>0.0125). However, there was a significant difference in superior sagittal sinus CT values between the groups (P<0.0125). Group A showed more venous contamination (P<0.025), and its superior sagittal sinus CT value was significantly higher than the expert consensus-recommended value of 150 HU (P<0.0125). CONCLUSIONS CTA before CTP had no significant effect on perfusion parameters and was associated with reduced venous contamination. This strategy may serve as a practical alternative in similar 64-slice CT one-stop-shop stroke protocols. |
Medical science monitor : international medical journal of experimental and clinical research | 2026 Oct 4 | PubMed |
| 13 |
Junctional plakoglobin regulates intestinal epithelial cell proliferation via MAPK/ERK signaling.
View abstractJunctional plakoglobin (JUP) is a desmosomal protein essential for epithelial tissue integrity and epithelial-immune cell crosstalk. Although JUP has been implicated in inflammatory processes, its role in intestinal epithelial repair remains unclear. In vitro, loss of JUP in Caco-2 monolayers and non-transformed intestinal organoids markedly accelerated wound closure, driven by enhanced epithelial cell migration and proliferation. RNA sequencing-based pathway analysis of organoids revealed activation of MAPK/ERK signaling following JUP deficiency. This effect was corroborated by increased ERK phosphorylation in Western blot analyses. In line with that, pharmacological inhibition of ERK abrogated the accelerated wound closure, confirming that MAPK/ERK signaling is critical for the phenotype. To further examine the relevance in vivo, we used an inducible, intestine-specific JUP knockout mouse model (iVilCreERJup). Following biopsy-induced intestinal injury, JUP deletion significantly enhanced mucosal repair, accompanied by increased cell proliferation and MAPK signaling, thereby confirming the in vitro results. Collectively, these findings establish JUP as a previously unrecognized regulator of epithelial cell dynamics and repair through MAPK/ERK signaling. |
Cell communication and signaling : CCS | 2026 Oct 3 | PubMed |
| 14 |
Sex, Racial/Ethnic, and Regional Disparities in Mortality Involving Both Cardiac Arrest and Type 2 Diabetes Mellitus Among U.S. Adults, 1999-2020.
View abstractAIMS: Type 2 Diabetes mellitus (T2DM) and cardiac arrest (CA) drive significant mortality and healthcare costs in the U.S., yet national trends and disparities remain unclear. This study aims to evaluate national trends in mortality involving concurrent T2DM and CA among the U.S. adult population. METHODS: Using Centers for Disease Control and Prevention Wide Ranging Online Data for Epidemiologic Research (CDC WONDER) database, we analyzed deaths among U.S. adults aged ≥ 25 (1999-2020) from T2DM (ICD-10: E11) and CA (ICD-10: I46), calculating crude and age-adjusted mortality rates (AAMR) per 100,000 and estimating annual percent change (APC) via Joinpoint regression stratified by sex, race/ethnicity, age and geography. RESULTS: Between 1999 and 2020, 258,675 deaths involving both T2DM and CA occurred. AAMRs increased from 1999 to 2014 (APC 2.72) and surged through 2020 (APC 9.55). Mortality was higher in men than in women (AAMR 6.75 vs. 4.36). Marked racial and ethnic disparities were observed, with the highest mortality rates among Hispanic (AAMR 10.92) and non-Hispanic (NH) American Indian/Alaska Native populations (10.16), while NH Whites had the lowest rates (4.35). The sharpest increases in AAMR were observed in younger adults. Geographically, the Western region and metropolitan areas exhibited the highest mortality burden. At the state level, California had the highest AAMR, whereas Maryland had the lowest. CONCLUSIONS: Mortality related to coexisting T2DM and CA increased substantially in the United States from 1999 to 2020, with an accelerated rise after 2014, particularly among younger adults and ethnic minorities. These findings highlight an urgent need for targeted cardiovascular preventive strategies in these high-risk cohorts. |
Journal of racial and ethnic health disparities | 2026 Oct 3 | PubMed |
| 15 |
The safety and tolerability of opicapone in elderly Parkinson's disease patients: a real-world, multicenter, retrospective study.
View abstractOpicapone (OPC) is an effective add-on medication for motor fluctuations in Parkinson's disease (PD), with a favorable safety and tolerability profile. Elderly PD patients are a great proportion of the real-world PD population, often underrepresented in clinical trials. This multicenter, retrospective, longitudinal study aimed to assess the real-world safety and tolerability of OPC in PD patients aged ≥ 65 years. Clinical-demographic data were collected at OPC initiation (T0) and at the last follow-up visit (T1). OPC-related adverse events (AEs) and reasons for discontinuation were recorded. Patients were compared according to age and treatment continuation. Logistic regression analyses were used to evaluate association between baseline features and occurrence of AEs and discontinuation. One-hundred and one elderly PD patients were included and followed up for 20.6 ± 18.8 months after OPC initiation. Overall, 49 patients (48.5%) reported AEs, and OPC was discontinued in 29 (28.7%) within 9.4 ± 15.3 months, with neuropsychiatric and cardiovascular/autonomic AEs being the most common reasons. Patients aged ≥ 75 years reported greater disease severity and frequency of AEs compared to younger patients, but similar discontinuation rates at follow-up. At T1, OPC discontinuers exhibited greater motor impairment and a lower total levodopa equivalent dose. Univariate analyses showed that age, disease stage, and comorbidity burden were significantly associated with AEs occurrence. In the multivariable analysis, disease stage remained the only significant baseline feature associated with AEs. OPC was generally well tolerated in this cohort of real-world elderly PD patients. Larger, prospective studies are warranted. |
Journal of neural transmission (Vienna, Austria : 1996) | 2026 Oct 3 | PubMed |
| 16 |
Metabolomic biomarkers and metabolic remodelling in genetically characterised hypertrophic cardiomyopathy: a systematic review.
View abstractINTRODUCTION: Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiomyopathy and a major cause of heart failure, malignant arrhythmias and sudden cardiac death. Although pathogenic variants in sarcomeric genes such as MYBPC3, MYH7, TNNT2, and TNNI3 are well-recognised contributors to the disease, the mechanisms linking these mutations to the heterogeneous phenotypes remain poorly understood. Increasing evidence suggests that HCM is fundamentally associated with disturbances in myocardial energetics and metabolic remodelling. OBJECTIVES: This systematic review aimed to synthesise metabolomic evidence from genetically characterised HCM cohorts, with three specific objectives: (1) to characterise the metabolic pathways dysregulated in HCM, (2) to determine whether distinct metabolic signatures are associated with specific sarcomeric gene variants and (3) to evaluate the diagnostic, prognostic, and therapeutic relevance of identified metabolite biomarkers in HCM management. By explicitly examining whether genotype-specific metabolomic signatures exist in the current literature, this review addresses a question of direct relevance to precision medicine approaches in HCM. METHODS: A systematic search of PubMed, Scopus and Web of Science identified 14 eligible studies comprising 1511 participants. RESULTS: Most studies employed liquid chromatography-mass spectrometry (LCMS) based metabolomics using plasma or myocardial tissue samples. Across studies, recurrent metabolic alterations were observed in pathways related to fatty acid oxidation, branched-chain amino acid (BCAA) metabolism, ketone body utilisation, tricarboxylic acid (TCA) cycle intermediates and lipid metabolism. Circulating acyl carnitines, amino acids, and eicosanoid metabolites were among the most frequently reported biomarkers associated with disease presence or severity. Myocardial tissue analyses demonstrated impaired mitochondrial energetics, reductions in high-energy phosphate metabolites, and shifts toward alternative metabolic substrates. CONCLUSION: No distinct genotype-specific metabolic signature was identified across studies; the metabolic remodelling pattern reflected phenotypic severity rather than the causal variants. While metabolomics shows potential in improving disease characterisation and biomarker discovery, further longitudinal and externally validated studies are required before clinical translation. |
Metabolomics : Official journal of the Metabolomic Society | 2026 Oct 3 | PubMed |
| 17 |
Metabolic vulnerabilities in multiple myeloma: targeting iron and amino acid metabolism to induce ferroptosis.
View abstractCould ferroptosis, a novel cell death pathway, offer a potential therapeutic strategy for multiple myeloma (MM)? Our previous research showed that ferroptosis is suppressed in MM patients, with varying sensitivities among MM cells. In this study, metabolomic analysis highlighted the pivotal role of amino acid metabolism, rather than lipid metabolism, in determining MM cells' sensitivity to ferroptosis. We further analyzed iron metabolism, another key factor influencing ferroptosis sensitivity, by collecting peripheral blood samples from 120 MM patients. Our analysis revealed a significant reduction in the levels of transferrin (TF), an essential iron-transporting protein. Moreover, low TF levels were associated with significantly worse progression-free survival and overall survival. Erastin treatment together with TF supplementation markedly enhanced ferroptosis in MM cells in vitro and in xenograft models. MM cells suppressed TF secretion by monocytes in the bone marrow microenvironment, contributing to the decreased TF levels in MM patients. The transcription factor CEBPB, found in MM cell-derived extracellular vesicles, plays a key role in this process. In conclusion, Our findings identify amino acid metabolism and iron metabolism as distinct metabolic features associated with ferroptosis sensitivity in MM. Ferroptosis, induced by erastin and TF, holds promise as a potential therapeutic strategy for MM and provides new insights for developing more effective therapies. |
Apoptosis : an international journal on programmed cell death | 2026 Oct 3 | PubMed |
| 18 |
Statins are associated with decreased risk of disease progression and death in non-cirrhotic patients with primary biliary cholangitis.
View abstractBACKGROUND/AIMS: We evaluated whether statins in non-cirrhotic patients with primary biliary cholangitis (PBC) might influence disease progression, including cirrhosis development, hepatic decompensation, all-cause mortality, liver-related death (LRD) and non-liver-related death (NLRD), as such data are missing. MATERIALS AND METHODS: We retrospectively analyzed prospectively collected data in 507 non-cirrhotic PBC patients (445 females, age: 53 (16) years, follow-up: 85 (130) months) including 232 that received statins due to increased cardiovascular risk and 275 that had no treatment with statins during the follow-up. RESULTS: There were no significant differences between the two groups in baseline demographic, clinical and laboratory characteristics except for higher cholesterol, LDL and triglyceride levels and higher frequency of MASLD/MASH in statin users. No differences in treatment response to UDCA (GLOBE score, Paris II) were noted between the groups. Statin users had lower rate of cirrhosis development (3.4% vs. 8%; p=0.03), hepatic decompensation (0.4% vs 4.7%; p=0.003), lower all-cause mortality (3.9% vs. 16.4%; p<0.001), LRD (0.4% vs. 5.1%; p=0.002) and NLRD (3.4% vs. 11.3%; p,0.001) compared to no-statin users. A time-dependent Cox regression analysis revealed significantly higher cirrhosis-free survival (HR=0.139; 95%CI 0.041-0.467, p=0.001) and significantly lower risk of all-cause mortality (HR=0.318; 95%CI 0.153-0.661, p=0.002) and LRDs (HR=0.076; 95%CI 0.010-0.584, p=0.013), while no significant difference was found regarding NLRDs (HR=0.499; 95%CI 0.224-1.111, p=0.089) in statin users compared to non-users. CONCLUSIONS: Statins seem to independently associate with higher cirrhosis-free survival and lower overall and liver-related mortality in non-cirrhotic patients with PBC. Larger prospective studies are needed to confirm our novel data. |
European journal of internal medicine | 2026 Oct 3 | PubMed |
| 19 |
Venous But Not Arterial Graft Failure Associated with Ischaemic Sequelae After Coronary Bypass Surgery.
View abstractBACKGROUND: Late survival after coronary artery bypass grafting may depend not only on patency of the graft but also on patency of the proximal coronary lesion in the event of graft failure. Reduced proximal coronary patency following graft failure may be associated with ischaemic sequelae, potentially affecting postoperative survival. Arterial and venous conduits follow distinct mechanisms of failure, and the postoperative patency status of the proximal coronary stenosis has not been widely considered in this context. METHOD: Patients underwent predominantly symptom-indicated coronary angiography between August 1997 and March 2020, following coronary artery bypass grafting. Patients with greater than or equal to one angiographically occluded graft distal to a coronary lesion that was patent at surgery, were primarily analysed. For each occluded graft, the coronary lesion proximal to the anastomosis was assessed for preservation of patency on postoperative angiography. The occurrence of non-fatal non-ST-segment elevation myocardial infarction (NSTEMI) in symptomatic patients undergoing postoperative angiography, with and without graft failure, was evaluated in a secondary analysis. Primary graft-level outcomes were analysed using exchangeable Generalised Estimating Equations binary logistic regression, and secondary patient-level outcomes were analysed using binary logistic regression. RESULTS: Overall, 145 patients were included in the primary analysis, with a mean follow-up of 9.2±5.6 years after surgery. Native coronary patency was 100% at surgery, with a similar degree of stenosis proximal to occluded arterial conduits and saphenous vein grafts (SVGs), 68.2±16.5% vs 72.2±15.7%, respectively, (p=0.216). At postoperative angiography, proximal coronary patency was more frequently preserved with occluded arterial grafts than with occluded SVGs, 83.1% (133/160) vs 38.7% (12/31) (odds ratio [OR] 4.96; 95% confidence interval [CI] 1.91-12.89; p=0.001). Among 179 symptomatic patients in the secondary analysis with greater than or equal to one SVG, NSTEMI occurred more frequently in those with SVG failure than in those without SVG failure, 42.2% vs 17.9% (OR 3.35; 95% CI 1.60-7.01; p=0.001). Among 563 symptomatic patients who underwent total arterial revascularisation, the frequency of NSTEMI was similar in those with and without arterial graft failure, 20.8% vs 24.4% (OR=0.81, 95% CI 0.52-1.27; p=0.360). CONCLUSIONS: Venous, but not arterial, graft failure is associated with reduced proximal coronary lesion patency, which may contribute to ischaemic sequelae. |
Heart, lung & circulation | 2026 Oct 3 | PubMed |
| 20 |
Marked Variability in Lipid Profile Reporting Among Australian Pathology Providers: A National Cross-Sectional Review of Low-Density Lipoprotein Cholesterol.
View abstractBACKGROUND: Lipid profiles facilitate cardiovascular risk stratification, therapeutic monitoring, and patient education. Variability in pathology reporting practices may generate confusion among clinicians and patients. While there is a central accreditation body for the provision of pathology in Australia, reporting formats are not regulated. This study aimed to characterise the variation in reporting of low-density lipoprotein cholesterol (LDL-C) levels among Australian pathology providers. METHOD: A cross-sectional national review was conducted in November 2024. Public and private pathology laboratory networks from every Australian state and territory, accredited by the Royal College of Pathologists of Australasia, were contacted via structured interviews and invited to submit de-identified or template lipid panel reports. RESULTS: Seventeen of the 18 laboratory networks contacted provided data. Six were state-wide centralised public pathology providers, eight were individual public hospital laboratory networks, and three were national private pathology networks. Six different LDL-C upper reference limits were observed (range, 2.0-3.7 mmol/L). Formatting practices for abnormal values varied significantly. Only four pathology networks provided individualised interpretative comments. Among the eight laboratory networks that included recommendations for familial dyslipidaemia investigation, LDL-C cut-offs differed considerably. Seven different guidelines were referenced in the reports, and none reflected contemporary recommendations. CONCLUSIONS: The format and content of lipid panel reporting varied widely across Australian pathology providers. Referenced guidelines were outdated, and this likely contributes to misunderstanding of contemporary treatment targets for both patients and clinicians. Harmonised lipid panel reporting may significantly improve dyslipidaemia management. |
Heart, lung & circulation | 2026 Oct 3 | PubMed |
| 21 |
Patency and functional outcomes of endovascular treatment in juxta-anastomotic venous stenosis of native arteriovenous fistulas.
View abstractINTRODUCTION: Juxta-anastomotic venous stenosis is a frequent cause of dysfunction in native arteriovenous fistula (AVFs), compromising both maturation and long-term patency. Endovascular treatment has emerged as a minimally invasive alternative to surgical revision. We evaluated short-term patency and functionality outcomes and temporal patterns following endovascular treatment of juxta-anastomotic venous stenosis. MATERIALS AND METHODS: We conducted a retrospective single-center observational study including adult patients with native AVFs who underwent endovascular treatment for juxta-anastomotic venous stenosis between January 2020, and June 2024. Analyses were performed at the patient level using the first (index) intervention. Assisted primary patency was assessed using Kaplan-Meier survival analysis. Exploratory associations with 6-month failure were evaluated using penalized logistic regression. RESULTS: Fifty patients were included. Median age was 72 years [IQR: 65-76], and 72% of patients were male, with a high burden of cardiovascular comorbidity. At intervention, 72% were on hemodialysis and 28% were followed in advanced chronic kidney disease (ACKD). Delayed AVF maturation accounted for 46% of cases. The median time from AVF creation to stenosis detection was 112.5 days (IQR 60.5-511), indicating heterogeneous temporal presentation. Stenosis was detected significantly earlier in AVFs treated for delayed maturation compared with established accesses (median 68.5 vs 388.5 days; p=0.001). Conventional balloon angioplasty was performed in 98% of index procedures, with selective use of cutting balloons and drug-coated balloons. During 6-months of follow-up, 8 access failures occurred. Kaplan-Meier estimates of assisted primary patency were 90% at 90 days (95% CI 0.78-0.96) and 84% at 180 days (95% CI 0.71-0.92). Functional success at 6-months was 90% of patients. CONCLUSIONS: In this single-center retrospective cohort, endovascular treatment was associated with high short-term assisted primary patency and functional success. These results represent real-world descriptive data and require confirmation in prospective studies with longer follow-up and comparative designs. . |
Nefrologia | 2026 Oct | PubMed |
| 22 |
Haemodynamic and neurophysiological assessments for 2-year outcome prediction in neonates with hypoxic-ischaemic encephalopathy treated with therapeutic hypothermia: a systematic review and meta-analysis.
View abstractOBJECTIVE: To evaluate the prognostic accuracy of amplitude-integrated electroencephalography (aEEG), cerebral near-infrared spectroscopy (cNIRS) and targeted neonatal echocardiography (TnECHO) for predicting 2-year outcomes (neurodevelopment and/or death) in infants with hypoxic-ischaemic encephalopathy (HIE) treated with therapeutic hypothermia (TH). DESIGN: Systematic review and meta-analysis. DATA SOURCES: MEDLINE, Embase, CINAHL and the Cochrane Library (2002-16 April 2025). PROSPERO registration: CRD42023387592. ELIGIBILITY CRITERIA: Prognostic studies including infants ≥35 weeks' gestation with HIE treated with whole-body TH and reporting neurodevelopmental impairment at 18-24 months and/or death. DATA EXTRACTION AND SYNTHESIS: Data were extracted independently. Risk of bias was assessed using Quality in Prognosis Studies. Pooled sensitivity, specificity, diagnostic ORs (DORs) and area under the curve (AUC) estimates were calculated using random-effects models. RESULTS: 37 studies (n=2721) were included; 24 (n=1989) contributed to meta-analysis. Abnormal aEEG background at 36 hours predicted adverse 2-year outcomes with sensitivity 0.83 (95% CI 0.70 to 0.92), specificity 0.88 (95% CI 0.79 to 0.93), DOR 33.06 (95% CI 12.87 to 84.94), AUC (0.88). Absence of sleep-wake cycling had high specificity 0.93 (95% CI 0.88 to 0.96), DOR 30.19 (95% CI 14.47 to 63.01) and AUC 0.88. Abnormal cNIRS demonstrated potential prognostic value at 36-48 hours with specificity 0.97 (95% CI 0.13-1.00), DOR 26.74 (95% CI 4.55 to 157.14) and AUC (0.86) at 36 hours. Acute pulmonary hypertension showed low overall discrimination, DOR 2.17 (95% CI 1.35 to 3.47) and (AUC 0.40). Right ventricular dysfunction showed higher specificity but substantial heterogeneity. CONCLUSIONS: Abnormal aEEG background at 36 hours provides reliable bedside prognostic information for 2-year outcomes in HIE. cNIRS may offer complementary value, whereas there is limited evidence supporting the utility of TnECHO alone. Multimodal methods may improve early prognostication. |
BMJ paediatrics open | 2026 Oct 3 | PubMed |
| 23 |
Development and Evaluation of a Trauma-Informed Women's Health Education Program for Intimate Partner Violence Survivors: A Mixed-Methods Study.
View abstractWomen with a history of intimate partner violence (IPV) are at increased risk for cardiovascular disease, human papillomavirus (HPV), cervical cancer, and human immunodeficiency virus (HIV), which we collectively termed women's health issues (WHIs). This study aimed to educate IPV survivors through a trauma-informed, WHI education program tailored to the needs and experiences of IPV victims, based on focus group data. An education program was created using data from 10 focus groups ( = 38), and these interactive presentations on WHIs were presented to IPV survivors ( = 69). Participants completed demographic surveys, including questions about physician acknowledgment of IPV as a risk factor for chronic conditions, and pre-post tests to evaluate the effectiveness of the educational sessions. Education session data revealed that 39% of participants had never heard of HPV, 38% had not received a Pap smear in the last 3 years, and 15% did not know where to get tested for HIV. Only 15% ( = 10) of participants reported that their physician acknowledged IPV as a risk factor for disease. Following the health education, there was a significant normalized gain of 55.66%, with paired tests comparing pretest/posttest scores supporting understanding of WHIs ( < .01). Tailored education modules about WHIs proved effective in educating women who have experienced IPV. Future iterations will focus on topics informed by participant responses, such as diabetes mellitus, neurological disorders, reproductive health, and gastrointestinal diseases. This study opens avenues for further exploration of the connection between IPV and health initiatives. |
Violence and victims | 2026 Oct 3 | PubMed |
| 24 | A Tribute by The Editorial Board of the American Journal of Medicine. Our Retrospective and an Interview with the Outgoing Editor, Joseph S. Alpert, MD MACP. | The American journal of medicine | 2026 Oct 3 | PubMed |
| 25 |
Thrombin Generation in Critically Ill Adults: A Systematic Review of Venous Thromboembolism and Pharmacological Thromboprophylaxis.
View abstractBACKGROUND: Venous thromboembolism (VTE) remains an important complication in critically ill adults despite standard pharmacological thromboprophylaxis. Thrombin generation assays (TGAs) offer a global functional assessment of coagulation by capturing the kinetics and magnitude of thrombin formation and may complement conventional measures of coagulation such as anti-Xa activity. METHODS: The review was conducted according to JBI methodology and reported per PRISMA guidelines. We searched MEDLINE, Embase, and CENTRAL from inception to December 18, 2025. We included studies of adults (≥18 years) managed in high-acuity or intensive care settings with TGA measurements reported in relation to VTE incidence or thromboprophylaxis effect. RESULTS: We included 15 eligible prospective studies comprising 2,250 patients (9 surgical trauma cohorts, 4 medical ICU cohorts, 2 mixed ICU cohorts). Calibrated automated thrombography (CAT) was the most used TGA platform (80.0%). Eleven studies (73.3%) evaluated associations between TGA and VTE incidence, with inconsistent findings. Some trauma cohorts identified shorter time-to-peak thrombin or lag time as predictors of VTE, while other studies found no significant associations. Of eight studies (53.3%) assessing TGA pharmacodynamics, seven measured anti-Xa activity, which correlated with lower endogenous thrombin potential and peak thrombin. CONCLUSION: TGA most consistently served as a pharmacodynamic measure of low-molecular-weight heparin effect: anti-Xa activity correlated with suppressed endogenous thrombin potential and peak thrombin. TGA did not reliably predict VTE, though shorter time-to-peak and lag time preceded thrombosis in trauma cohorts. TGA should be advanced as a coagulation-phenotyping tool in prospective ICU studies with standardized assays, consistent sampling in relation to dose timing, and concurrent anti-Xa and thrombin generation measurement. |
Journal of thrombosis and haemostasis : JTH | 2026 Oct 3 | PubMed |

